Close

Ziopharm Oncology (ZIOP), Intrexon (XON) Partner with Merck Serono to Strengthen CAR-T Platform

March 30, 2015 8:07 AM EDT Send to a Friend
Ziopharm Oncology (NASDAQ: ZIOP) and Intrexon Corporation (NYSE: XON) announced their oncology programs will be strengthened through Intrexon's new global ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login